An Integrated Systematic Review and Meta‐Analysis From the Bloodstream to Identify Potential Biomarkers for ALD, MASLD, and HCC Without a Viral Background
Journal of Gastroenterology and Hepatology · 2026
DOI: 10.1111/jgh.70228 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Gastroenterology and Hepatology, 2026. Verfasst von Karina González-García und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Fibrosis and Cancer, Faculty of Medicine and Surgery, Autonomous University "Benito Juarez" of Oaxaca, Oaxaca, Mexico. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Liver Diseases, Alcoholic, Fatty Liver. Die Arbeit nennt 106 Literaturangaben. Gefördert von: SECIHTI.
Abstract (Originalsprache)
Chronic non‐viral liver diseases (CNVLD), including alcohol‐related liver disease (ALD) and metabolic dysfunction–associated steatotic liver disease (MASLD), have increased in prevalence, surpassing viral hepatitis as the main cause of hepatocellular carcinoma (HCC) in the last decade; thus, the identification of bloodstream biomarkers is essential for early diagnosis, risk stratification, and monitoring progression. This study aimed to systematically integrate and compare proteomic evidence from blood‐based studies to identify differentially expressed proteins (DEPs) associated with ALD, MASLD, and HCC of non‐viral etiology, to prioritize them as candidates for shared biomarkers and diagnostics for each disease. A systematic review was conducted, followed by a qualitative meta‐analysis to identify DEPs bloodstream biomarkers. Biomarkers were compared across diseases to detect overlaps. Functional enrichment, network, and topological analyses were used to evaluate their biological relevance. We identified 16 diagnostic biomarkers for ALD, 53 for MASLD, and 8 for HCC. Four biomarkers were shared among ALD and MASLD, two among ALD and HCC, and two among MASLD and HCC. Functional analyses indicated platelet dysfunction and coagulation pathway alterations in ALD; lipid metabolism dysregulation in MASLD; and a combination of these processes in HCC patients. Network analysis highlighted key biomarkers with potential diagnostic and prognostic applications. The identified biomarkers reflect both shared and disease‐specific molecular mechanisms in the progression of CNVLD toward HCC. Their consistent presence across independent studies supports their potential integration into diagnostic and prognostic panels, particularly in the context of the rising prevalence of ALD and MASLD worldwide.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Fibrosis and Cancer, Faculty of Medicine and Surgery, Autonomous University "Benito Juarez" of Oaxaca, Oaxaca, Mexico.
- Laboratory of Experimental Hepatology, Department of Pharmacology, Center for Research and Advanced Studies of the National Polytechnic Institute (CINVESTAV-IPN), Mexico City, Mexico.
- Department of Cell Biology, Center for Research and Advanced Studies of the National Polytechnic Institute (CINVESTAV-IPN), Mexico City, Mexico.
- Liver Disease Laboratory, SECIHTI-National Institute of Genomic Medicine (INMEGEN), Mexico City, Mexico.
- SECIHTI-Faculty of Medicine and Surgery, Autonomous University "Benito Juarez" of Oaxaca, Oaxaca, Mexico.
ORCID-Profile: Verónica Rocío Vásquez-Garzón
Förderung
- SECIHTI
Zitieren
APA
González-García, K., Zertuche-Martínez, C., Reyes-Avendaño, I., Reyes-Jiménez, E., Muriel, P., Villa-Treviño, S., Arellanes-Robledo, J., Baltiérrez-Hoyos, R., & Vásquez-Garzón, V. R. (2026). An Integrated Systematic Review and Meta‐Analysis From the Bloodstream to Identify Potential Biomarkers for ALD, MASLD, and HCC Without a Viral Background. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70228
Vancouver
González-García K, Zertuche-Martínez C, Reyes-Avendaño I, Reyes-Jiménez E, Muriel P, Villa-Treviño S, et al. An Integrated Systematic Review and Meta‐Analysis From the Bloodstream to Identify Potential Biomarkers for ALD, MASLD, and HCC Without a Viral Background. Journal of Gastroenterology and Hepatology. 2026. doi:10.1111/jgh.70228
BibTeX
@article{GonzlezGarca2026,
author = {González-García, Karina and Zertuche-Martínez, Cecilia and Reyes-Avendaño, Itayetzi and Reyes-Jiménez, Edilburga and Muriel, Pablo and Villa-Treviño, Saúl and Arellanes-Robledo, Jaime and Baltiérrez-Hoyos, Rafael and Vásquez-Garzón, Verónica Rocío},
title = {An Integrated Systematic Review and Meta‐Analysis From the Bloodstream to Identify Potential Biomarkers for ALD, MASLD, and HCC Without a Viral Background},
journal = {Journal of Gastroenterology and Hepatology},
year = {2026},
doi = {10.1111/jgh.70228}
}
EUVIMED